[Pacemaker Current Gene Expression of Rat Mesenchymal Stem Cells and Identification of Mesenchymal Stem Cells Expressing Human Pacemaker Current Gene (Hhcn2)].

Hong-xia Li,Xiang-jun Yang,Xin Zhao,Bin Jiang,Xu-jie Cheng,Tan Chen,Lian-hua Han,Jian-ping Song,Zhi-hua Liu,Wen-ping Jiang
DOI: https://doi.org/10.3760/j:issn:0253-3758.2006.10.015
2006-01-01
Abstract:OBJECTIVE:To study pacemaker current gene expression of mesenchymal stem cells (MSCs) and the electrophysiological property of MSCs expressing human pacemaker current gene.METHODS:Pacemaker current gene expression of MSCs were studied by real-time quantitative polymerase chain reaction (real-time PCR) and pcDNA3-hHCN2 was transfected with Lipofectin 2000 into MSCs. hHCN2 expression at mRNA and at protein levels in the transfected cells were identified by real-time PCR and Western blot, respectively. The ionic currents of cloned hHCN2 (IhHCN2) were recorded and the current characteristics were studied through the whole-cell patch clamp technique.RESULTS:mHCN1, mHCN2, mHCN3, mHCN4 represent (0.08+/-0.01)%, (77.16+/-0.03)%, (0.24+/-0.01)%, (22.53+/-0.02)% of total HCN mRNA in MSCs as determined by real-time PCR. Transfected hHCN2 ionic currents were recorded by whole-cell patch clamp and current density-voltage curves were obtained. The threshold for activation of IhHCN2 was approximately -80 mV and this current could be blocked by Cs+ (4 mmol/L). hHCN2 expression in transfected MSCs was detected both at mRNA and protein levels.CONCLUSIONS:1. mHCN2 and mHCN4 represent the major populations of total HCN mRNA in MSCs. 2. Plasmid pcDNA3-hHCN2 by Lipofectin could be successfully transfected into MSCs with IhHCN2 recorded by whole-cell patch clamp technique, this study provides a basis for future antiarrhythmic gene therapy.
What problem does this paper attempt to address?